Wright Medical Group, Inc. Announces Exclusive Agreement with ArthroCare® Corporation for Foot and Ankle Product

ARLINGTON, Tenn.—July 13, 2011—Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced a supply and distribution agreement with ArthroCare Corporation, a leading company in orthopaedic sports medicine. ArthroCare will supply Wright with products for soft tissue fixation of the foot and ankle based on ArthroCare’s market-leading knotless suturing technology.
The agreement with ArthroCare includes a line of tissue fixation devices based on ArthroCare’s Opus® knotless suture fixation technology, which Wright will distribute exclusively to foot and ankle surgeons worldwide. ArthroCare’s patented Opus® technology allows surgeons to affix tendons and ligaments to bony structures efficiently and reproducibly, without the need to tie knots. ArthroCare’s fixation technology is widely used in the rotator cuff repair market and has been used clinically since 2001 in
more than 100,000 procedures worldwide.
Bob Fencl, Senior Director of Foot and Ankle Marketing at Wright, commented “We are extremely pleased to enter this agreement with ArthroCare. Soft tissue repair is a cornerstone of foot and ankle surgery, and this agreement allows Wright to deliver another innovative technology to our customers.”
Wright Medical expects to commercialize products through this relationship during the second half of 2011 through its dedicated foot and ankle sales force.

Share your thoughts

Your email address will not be published. Required fields are marked *